-The Hindu While the Internet growth story in India seems promising, individual users are yet to play their rightful role. Individual consumption is placed at 29 per cent — much lower than the international figure of 45 per cent, which means the Internet economy in India continues to be driven by large companies. By 2015, the Internet sector is projected to become bigger than the education sector, and equal to the...

-The Times of India India will, for the first time, put a cap on the maximum price at which essential drugs, like some commonly used anti-AIDS and anti-cancer drugs, besides a horde of painkillers, anti-TB drugs, sedatives, lipid lowering agents and steroids, can be sold in the country. In a landmark decision, a group of ministers (GoM) headed by agriculture minister Sharad Pawar on Thursday cleared the proposal to bring all 348...

-Bloomberg It wasn't the Gettsyburg Address -- unless it's poker faces we're comparing. Future historians aren't going to be parsing Prime Minister Manmohan Singh's speech for hidden meanings, and rhetoricians won't be delighting in the majesty of its style and the compression of its effects. It inflamed no passions, as did Mitt Romney's words about the "47 percent," and asserted no big idea or thesis, unless there was one contained in the...

-The Economic Times New discoveries of natural resources in several African countries - including Ghana, Uganda, Tanzania, and Mozambique - raise an important question: will these windfalls be a blessing that brings prosperity and hope, or a political and economic curse, as has been the case in so many countries? On average, resource-rich countries have done even more poorly than countries without resources. They have grown more slowly, and with greater inequality...

-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...